Sign in

CIK 0001833769

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Hyperfine, Inc.

Sign in to watch
Ticker
HYPR
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 866-796-6767
Business address
351 NEW WHITFIELD STREET, GUILFORD, CT, 06437
Former names
HealthCor Catalio Acquisition Corp.
  1. 4 Open-market buy President and CEO bought 5,000 shares at $0.95 ($4,750)
  2. 4/A Open-market buy President and CEO bought 12,425 shares at $0.85 ($10,561)
  3. 4/A Open-market buy President and CEO bought 2,575 shares at $0.83 ($2,137)
  4. 4 Grant or award President and CEO acquired 12,425 shares (grant or award)
  5. 4 Grant or award President and CEO acquired 2,575 shares (grant or award)
  6. 4 Open-market buy Director bought 229,215 shares at $0.82 ($187,956)
  7. 4 Open-market buy Director bought 47,007 shares at $0.72 ($33,845)
  8. 4 Open-market sale CMO and Chief Strategy Officer sold 1,039 shares at $84.00 ($87,276)
  9. 4 Open-market sale Gen Counsel & Corp Secretary sold 1,895 shares at $0.84 ($1,592)
  10. 4 Open-market sale Chief Financial Officer sold 2,227 shares at $0.84 ($1,871)
  11. 4 Open-market buy Director bought 31,139 shares at $0.92 ($28,648)
  12. 4 Open-market buy Director bought 34,488 shares at $0.89 ($30,694)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market sale CMO and Chief Strategy Officer sold 1,035 shares at $1.45 ($1,501)
  20. 4 Open-market sale Chief Financial Officer sold 8,871 shares at $1.45 ($12,863)

Page 4 of 8 · 144 filings